Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17β-estradiol or a peroxisome proliferator

Journal of Steroid Biochemistry and Molecular Biology

Volumn 79, Issue 1-5, 2001, Pages 11-17

  Toda, Katsumi ^a   Takeda, Kiyoshi ^b   Akira, Shizuo ^b   Saibara, Toshiji ^a   Okada, Teruhiko ^a   Onishi, Saburo ^a   Shizuta, Yutaka ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Aromatase; Cyp19; Fatty acid oxidation; Hepatic steatosis; Knockout mouse; Peroxisome proliferator activated receptor

Indexed keywords

APOLIPOPROTEIN E; BEZAFIBRATE; ESTRADIOL; FATTY ACID; LIPOPROTEIN; MESSENGER RNA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHEMICAL ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYP19 GENE; FATTY ACID OXIDATION; FATTY LIVER; GENE; GENE DISRUPTION; GENE EXPRESSION; KNOCKOUT MOUSE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; WILD TYPE;

ACYL-COA DEHYDROGENASE; ACYL-COA OXIDASE; ALKANE 1-MONOOXYGENASE; ANIMALS; AROMATASE; BEZAFIBRATE; CATALASE; COENZYME A LIGASES; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; FATTY ACID DESATURASES; FATTY ACIDS; GENE EXPRESSION; LIPID METABOLISM; LIPOPROTEINS; LIVER; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MIXED FUNCTION OXYGENASES; OXIDATION-REDUCTION; OXIDOREDUCTASES; PEROXISOME PROLIFERATORS; REPRESSOR PROTEINS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0035716162     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00135-2     Document Type: Conference Paper

References (28)

1. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
2. Estrogen: Consequences and implications of human mutations in synthesis and action
3. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women
4. Effects of ethinyl estradiol on serum lipoprotein lipids in male and female rats
5. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
6. Aortic permeability to LDL during estrogen therapy: A study in normocholesterolemic rabbits
7. The effects of reproductive hormones on serum lipoproteins: Unresolved issues in biology and clinical practice
8. Aromatase expression in health and disease
9. Concentrations of monoamines and acetylcholine in the brains of mice lacking the aromatase cytochrome P450 gene
10. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice
11. Effects of administration of di-(2-ethylhexyl) phthalate on rat liver mitochondria
12. Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2
13. The functional characteristics of a human apolipoprotein E variant (cystine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia
14. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma
15. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
16. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation
17. Estrogen receptor null mice: What have we learned and where will they lead us?
18. Tamoxifen-induced fatty liver in patients with breast cancer
19. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis
20. Non-alcoholic steatohepatitis
21. In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice
22. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse
23. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
24. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPAR-α)
25. Peroxisomal beta-oxidation enzymes
26. Peroxisome proliferator-activated receptor-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
27. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase